Maruti
bullish highMaruti Suzuki reported a strong Q2 FY24 with record quarterly sales volume of 552,055 units, net sales of INR 35,535 crore (up 24.5% YoY), and net profit of INR 3,716 crore (up 80% YoY).
Read Maruti analysis →Side-by-side earnings comparison across financial stats, AI summaries, management guidance, risks, quotes, and accountability signals.
Maruti Suzuki reported a strong Q2 FY24 with record quarterly sales volume of 552,055 units, net sales of INR 35,535 crore (up 24.5% YoY), and net profit of INR 3,716 crore (up 80% YoY).
Read Maruti analysis →Bajaj Finserv delivered a strong Q2 FY24 with consolidated revenue up 25% YoY to INR 26,023 crore and PAT up 24% YoY to INR 1,929 crore.
Read Bajajfinsv analysis →Maruti Suzuki reported a strong Q2 FY24 with record quarterly sales volume of 552,055 units, net sales of INR 35,535 crore (up 24.5% YoY), and net profit of INR 3,716 crore (up 80% YoY). The company gained 120 bps market share in PVs and achieved leadership in the SUV segment with ~23% share. Growth was driven by easing semiconductor shortages, favorable commodity prices (especially precious metals), cost reduction efforts, and a richer product mix. Management remains cautiously optimistic on demand, with festive season industry growth of ~18% so far. However, the small car segment continues to weaken due to affordability issues, and pending orders have reduced to ~250,000 units. Key risk: rising steel prices could pressure margins in H2.
Bajaj Finserv delivered a strong Q2 FY24 with consolidated revenue up 25% YoY to INR 26,023 crore and PAT up 24% YoY to INR 1,929 crore. Growth was driven by robust performance across subsidiaries: BAGIC reported a 95.3% combined ratio (lowest in 14 quarters) and 39% PAT growth, while BALIC saw NBV growth of 25% to INR 237 crore. BFL continued its momentum with 33% AUM growth and asset quality improvement. The AMC business launched with INR 5,235 crore AUM. Management guided for continued balanced growth, with BAGIC targeting sub-100% combined ratio despite near-term investment costs. Key risk: elevated claims volatility in government health and crop insurance segments could pressure underwriting profitability.
Highest ever quarterly sales volume for the company.
Maruti achieved leadership in the SUV segment during Q2.
Order backlog reduced from 288,000 at end of Q2 to ~250,000 currently.
Discounts increased slightly from INR 16,214 in Q1 to INR 17,700 in Q2.
Lowest combined ratio in 14 quarters, driven by better expense ratios and reinsurance terms.
New business value growth supported by improved product mix and interest rate movement.
Strong AUM growth driven by diversified business model and customer acquisition.
Market share doubled from ~4% two years ago, driven by OEM tie-ups and long-term policies.
Management plans a threefold increase in export volumes from current levels to about 750,000-800,000 units by 2030-31.
Management guidance growthCapital expenditure for the current fiscal year is expected to exceed INR 8,000 crore.
Management guidance capexManagement expressed commitment to gradually recover market share to the 50% mark over time.
Management guidance growthDue to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing.
Management guidance marginsManagement expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Management guidance growthBFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.
Management guidance growthSteel prices have started increasing, which could negatively impact gross margins in Q3 and beyond.
medium · management_commentaryAffordability issues continue to depress small car demand, which remains a significant portion of Maruti's portfolio.
medium · management_commentaryAnalysts raised concerns about one-off gains and inventory adjustments boosting margins; management clarified no one-offs but acknowledged exceptional quarter with all positives aligning.
medium · analyst_questionShifting production mix towards SUVs may require investments in flexibility, potentially impacting near-term volumes and margins.
low · analyst_questionThe Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.
medium · management_commentaryBAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.
medium · management_commentaryAnalyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
medium · analyst_questionHigher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels.
medium · analyst_questionWe had all the positives in this quarter. We had everything which was positive. It's very unusual in a quarter that you have all that is positive.
The top 3% of India today owns a car. So if the car market has to grow, more people have to move from the 97% club to the 3% club. Sooner or later, it has to happen.
We have never done business in a desperate manner. We have always done business the way business should be done.
Our purpose is to create platform to carry out health transactions for customers. It's not about acquiring customers, it's all about enabling transactions digitally.